학술논문

Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study
Document Type
Journal
Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER; JUN 2023, 11 6, pe006747 11p.
Subject
Language
English
ISSN
20511426